These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 8831505)
1. Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo. Forough R; Koyama N; Hasenstab D; Lea H; Clowes M; Nikkari ST; Clowes AW Circ Res; 1996 Oct; 79(4):812-20. PubMed ID: 8831505 [TBL] [Abstract][Full Text] [Related]
2. Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. Zempo N; Koyama N; Kenagy RD; Lea HJ; Clowes AW Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):28-33. PubMed ID: 8548422 [TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated gene transfer of the human tissue inhibitor of metalloproteinase-2 blocks vascular smooth muscle cell invasiveness in vitro and modulates neointimal development in vivo. Cheng L; Mantile G; Pauly R; Nater C; Felici A; Monticone R; Bilato C; Gluzband YA; Crow MT; Stetler-Stevenson W; Capogrossi MC Circulation; 1998 Nov; 98(20):2195-201. PubMed ID: 9815875 [TBL] [Abstract][Full Text] [Related]
4. Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model. Allaire E; Forough R; Clowes M; Starcher B; Clowes AW J Clin Invest; 1998 Oct; 102(7):1413-20. PubMed ID: 9769334 [TBL] [Abstract][Full Text] [Related]
5. Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1. Lamfers ML; Grimbergen JM; Aalders MC; Havenga MJ; de Vries MR; Huisman LG; van Hinsbergh VW; Quax PH Circ Res; 2002 Nov; 91(10):945-52. PubMed ID: 12433840 [TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Mason DP; Kenagy RD; Hasenstab D; Bowen-Pope DF; Seifert RA; Coats S; Hawkins SM; Clowes AW Circ Res; 1999 Dec 3-17; 85(12):1179-85. PubMed ID: 10590245 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of human endothelial nitric oxide synthase in rat vascular smooth muscle cells and in balloon-injured carotid artery. Chen L; Daum G; Forough R; Clowes M; Walter U; Clowes AW Circ Res; 1998 May; 82(8):862-70. PubMed ID: 9576106 [TBL] [Abstract][Full Text] [Related]
8. Coordinated effects of fibroblast growth factor-2 on expression of fibrillar collagens, matrix metalloproteinases, and tissue inhibitors of matrix metalloproteinases by human vascular smooth muscle cells. Evidence for repressed collagen production and activated degradative capacity. Pickering JG; Ford CM; Tang B; Chow LH Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):475-82. PubMed ID: 9102165 [TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase and alphavbeta3 integrin-dependent vascular smooth muscle cell invasion through a type I collagen lattice. Kanda S; Kuzuya M; Ramos MA; Koike T; Yoshino K; Ikeda S; Iguchi A Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):998-1005. PubMed ID: 10764664 [TBL] [Abstract][Full Text] [Related]
11. Expression of tissue inhibitor of matrix metalloproteinases 1 by use of an adenoviral vector inhibits smooth muscle cell migration and reduces neointimal hyperplasia in the rat model of vascular balloon injury. Dollery CM; Humphries SE; McClelland A; Latchman DS; McEwan JR Circulation; 1999 Jun; 99(24):3199-205. PubMed ID: 10377085 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. Bendeck MP; Irvin C; Reidy MA Circ Res; 1996 Jan; 78(1):38-43. PubMed ID: 8603503 [TBL] [Abstract][Full Text] [Related]
14. Tissue inhibitor of metalloproteinases-4 suppresses vascular smooth muscle cell migration and induces cell apoptosis. Guo YH; Gao W; Li Q; Li PF; Yao PY; Chen K Life Sci; 2004 Oct; 75(20):2483-93. PubMed ID: 15350823 [TBL] [Abstract][Full Text] [Related]
15. Rat and human aortic smooth muscle cells display differing migration and matrix metalloproteinase activities in response to dexamethasone. Pross C; Farooq MM; Lane JS; Angle N; Tomono CK; Xavier AE; Freischlag JA; Collins AE; Law RE; Gelabert HA J Vasc Surg; 2002 Jun; 35(6):1253-9. PubMed ID: 12042738 [TBL] [Abstract][Full Text] [Related]
16. Effect of tissue plasminogen activator on vascular smooth muscle cells. Yang Z; Eton D; Zheng F; Livingstone AS; Yu H J Vasc Surg; 2005 Sep; 42(3):532-8. PubMed ID: 16171602 [TBL] [Abstract][Full Text] [Related]
17. [Effects of tissue inhibitor of matrix metalloproteinases-4 on the activities of matrix metalloproteinases and collagen of artery: experiment with rats]. Zu LY; Guo YH; Chen L; Li Q; Yan H; Gao W Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(7):472-5. PubMed ID: 16677575 [TBL] [Abstract][Full Text] [Related]
18. Tissue factor pathway inhibitor-2 is induced by fluid shear stress in vascular smooth muscle cells and affects cell proliferation and survival. Ekstrand J; Razuvaev A; Folkersen L; Roy J; Hedin U J Vasc Surg; 2010 Jul; 52(1):167-75. PubMed ID: 20537494 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of the inhibitory effect of epigallocatechin-3-gallate on cultured human vascular smooth muscle cell invasion. Cheng XW; Kuzuya M; Nakamura K; Liu Z; Di Q; Hasegawa J; Iwata M; Murohara T; Yokota M; Iguchi A Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1864-70. PubMed ID: 16051878 [TBL] [Abstract][Full Text] [Related]
20. Systemic tissue inhibitor of metalloproteinase-1 gene delivery reduces neointimal hyperplasia in balloon-injured rat carotid artery. Furman C; Luo Z; Walsh K; Duverger N; Copin C; Fruchart JC; Rouis M FEBS Lett; 2002 Nov; 531(2):122-6. PubMed ID: 12417298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]